tirzepatide patent expiry 2036 eli lilly FDA Approves Weight Drug, Now Set to Compete Against Novo's Wegovy Mounjaro patent expiration: Drug patents

Micro Pathog

Were hopeful that with continued advocacy, advancement in science, and data, we will continue to see improved access to this life-changing medication.

Women specific considerations Women generally require lower doses relative to body weight compared to men

Weve taken legal action to protect the American public and our intellectual property and will continue to work with regulators, law enforcement, and other key stakeholders to ensure patients have access to FDA approved safe and effective medicines. Also in February, Novo Nordisk announced approval from the European Commission for a more effective dose of the injectable form of Wegovy